Human nonmetastatic clone 23 type 1 gene suppresses migration of cervical cancer cells and enhances the migration inhibition of fungal immunomodulatory protein from Ganoderma tsugae

Reproductive Sciences

Volumn 14, Issue 5, 2007, Pages 475-485

  Wang, Po Hui ^a,b   Yang, Shun Fa ^b   Chen, Gin Den ^a,b   Han, Chih Ping ^a,b   Chen, Shiuan Chih ^a   Lin, Long Yau ^a,b   Ko, Jiunn Liang ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell invasion; Cell migration; Cervical cancer cells; Fungal immunomodulatory protein Ganoderma tsugae; Human nonmetastatic clone 23 type 1 gene; Matrix metalloproteinase

Indexed keywords

FUNGAL PROTEIN; GELATINASE A; GELATINASE B; PROTEIN FIP; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGUS; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR CLONING; NM23 H1 GENE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; CELL MOTION; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GANODERMA; GENETICS; HELA CELL; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE MIGRATION INHIBITION TEST; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL MOVEMENT; FEMALE; FUNGAL PROTEINS; GANODERMA; HELA CELLS; HUMANS; IMMUNOLOGIC FACTORS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 38449120142     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107305035     Document Type: Article

References (30)

1. Saraiya UB Preventable but not prevented: the reality of cervical cancer. J Obstet Gynaecol Res. 2003 ; 29: 351-359.
2. Steeg PS, Bevilacqua G., Kopper L., et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 ; 80: 200-204.
3. Lacombe ML, Milon L., Munier A., Mehus JG, Lambeth DO The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr. 2000 ; 32: 247-258.
4. Ouatas T., Salerno M., Palmieri D., Steeg PS Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr. 2003 ; 35: 73-79.
5. Ravazoula P., Aletra C., Kourounis G., Ladopoulos I., Tzigounis V. Immunohistochemical analysis of nm23-H1 expression in human cervical lesions. Eur J Gynaecol Oncol. 2000 ; 21: 510-512.
6. Rosengard AM, Krutzsch HC, Shearn A., et al. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature. 1989 ; 342: 177-180.
7. Wang PH, Chang H., Ko JL, Lin LY Nm23-H1 immunohistochemical expression in multisteps of cervical carcinogenesis. Int J Gynecol Cancer. 2003 ; 13: 325-330.
8. Wang PH, Ko JL, Chang H., Lin LY Clinical significance of high nm23-H1 expression in intraepithelial neoplasia and early-stage squamous cell carcinoma of the uterine cervix. Gynecol Obstet Invest. 2003 ; 55: 14-19.
9. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 ; 280: 1569-1575.
10. Risberg T., Lund E., Wist E., Kaasa S., Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol. 1998 ; 16: 6-12.
11. Gan KH, Fann YF, Hsu SH, Kuo KW, Lin CN Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J Nat Prod. 1998 ; 61: 485-487.
12. Liao CH, Hsiao YM, Hsu CP, et al. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line. Mol Carcinog. 2006 ; 45: 220-229.
13. Liotta LA, Tryggvason K., Garbisa S., Hart I., Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980 ; 284: 67-68.
14. John A., Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001 ; 7: 14-23.
15. Salerno M., Palmieri D., Bouadis A., Halverson D., Steeg PS Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras (SKR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol. 2005 ; 25: 1379-1388.
16. Hartsough MT, Morrison DK, Salerno M., et al. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem. 2002 ; 277: 32389-32399.
17. Hung CH, Lee MC, Lin MT, Lin JY Cloning and expression of the gene encoding Acacia confusa trypsin inhibitor that is active without post-translational proteolysis. Gene. 1993 ; 127: 215-219.
18. Boyden SV The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 ; 115: 453-466.
19. Albini A., Iwamoto Y., Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 ; 47: 3239-3245.
20. Sapi E., Flick MB, Rodov S., Kacinski BM Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res. 1998 ; 58: 1027-1033.
21. Kleiner DE, Stetler-Stevenson WG Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem. 1994 ; 218: 325-329.
22. Yang SF, Chu SC, Chiang IC, et al. Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia. Clin Chim Acta. 2005 ; 352: 209-215.
23. Che GW, Zhou QH, Zhu W., et al. Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1. Ai Zheng. 2005 ; 24: 278-284.
24. Che G., Zhou Q., Wang Y., et al. Effect of Nm23-H1 on reversing malignant phenotype on human lung cancer cell line L9981. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 ; 22: 530-534.
25. Lim S., Lee HY, Lee H. Inhibition of colonization and cell matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. Cancer Lett. 1998 ; 133: 143-149.
26. Garzetti GG, Ciavattini A., Lucarini G., Goteri G., Nictolis MD, Biagini G. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol. 1999 ; 61: 197-203.
27. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. 2002 ; 2: 163-176.
28. Matrisian L. The matrix-degrading metalloproteinases. Bioessays. 1992 ; 14: 455-463.
29. Nelson AR, Fingleton B., Rothenbers ML, Matrsian L. Matrix metalloproteinases: biologic and clinical implications. J Clin Oncol. 2000 ; 18: 1135-1149.
30. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K., Martin GR Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry. 1982 ; 21: 6188-6193.